Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?

Viani GA, Hamamura AC, Correa AC, de Arruda FT.

Int Braz J Urol. 2019 Jan 5;45. doi: 10.1590/S1677-5538.IBJU.2018.0039. [Epub ahead of print]

PMID:
30676298
2.

Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.

Fossati N, Karnes RJ, Colicchia M, Boorjian SA, Bossi A, Seisen T, Di Muzio N, Cozzarini C, Noris Chiorda B, Fiorino C, Gandaglia G, Dell'Oglio P, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Wiegel T, Montorsi F, Briganti A.

Eur Urol. 2017 Aug 2. pii: S0302-2838(17)30655-3. doi: 10.1016/j.eururo.2017.07.026. [Epub ahead of print]

PMID:
28779974
3.

Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.

Fossati N, Karnes RJ, Cozzarini C, Fiorino C, Gandaglia G, Joniau S, Boorjian SA, Goldner G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T, Briganti A.

Eur Urol. 2016 Apr;69(4):728-733. doi: 10.1016/j.eururo.2015.10.009. Epub 2015 Oct 21.

PMID:
26497924
4.

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.

Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):755-63.

PMID:
12788182
5.

Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.

Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T.

Eur Urol. 2014 Sep;66(3):479-86. doi: 10.1016/j.eururo.2013.11.045. Epub 2013 Dec 12.

PMID:
24345725
6.

Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study.

Fossati N, Robesti D, Karnes RJ, Soligo M, Boorjian SA, Bossi A, Coraggio G, Di Muzio N, Cozzarini C, Noris Chiorda B, Gandaglia G, Scarcella S, Bartkowiak D, Böhmer D, Shariat S, Goldner G, Battaglia A, Joniau S, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Wiegel T, Briganti A.

Eur Urol. 2019 Feb 21. pii: S0302-2838(19)30112-5. doi: 10.1016/j.eururo.2019.02.004. [Epub ahead of print]

PMID:
30799187
7.

Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.

Ying J, Wang CJ, Yan J, Liauw SL, Straka C, Pistenmaa D, Xie XJ, Lotan Y, Roehrborn C, Kim DN.

Am J Clin Oncol. 2017 Dec;40(6):612-620. doi: 10.1097/COC.0000000000000207.

PMID:
26165416
8.

Salvage radiation therapy for prostate cancer patients after prostatectomy.

Mima T, Ohori M, Hirasawa Y, Mikami R, Arai A, Hashimoto T, Satake N, Gondo T, Nakagami Y, Namiki K, Tokuuye K, Ohno Y.

Jpn J Clin Oncol. 2019 Jan 4. doi: 10.1093/jjco/hyy195. [Epub ahead of print]

PMID:
30608594
9.

Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.

Geinitz H, Riegel MG, Thamm R, Astner ST, Lewerenz C, Zimmermann F, Molls M, Nieder C.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1930-7. doi: 10.1016/j.ijrobp.2011.03.003. Epub 2011 Apr 22.

PMID:
21514736
10.

Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.

Bartkowiak D, Thamm R, Bottke D, Siegmann A, Böhmer D, Budach V, Wiegel T.

Acta Oncol. 2018 Mar;57(3):362-367. doi: 10.1080/0284186X.2017.1364869. Epub 2017 Aug 17.

PMID:
28816074
11.

Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy.

Ward JF, Zincke H, Bergstralh EJ, Slezak JM, Blute ML.

J Urol. 2004 Dec;172(6 Pt 1):2244-8.

PMID:
15538240
12.

Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.

Budäus L, Schiffmann J, Graefen M, Huland H, Tennstedt P, Siegmann A, Böhmer D, Budach V, Bartkowiak D, Wiegel T.

Strahlenther Onkol. 2017 Sep;193(9):692-699. doi: 10.1007/s00066-017-1140-y. Epub 2017 May 3.

PMID:
28470414
13.

Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.

Tilki D, Preisser F, Tennstedt P, Tober P, Mandel P, Schlomm T, Steuber T, Huland H, Schwarz R, Petersen C, Graefen M, Ahyai S.

BJU Int. 2017 May;119(5):717-723. doi: 10.1111/bju.13679. Epub 2016 Nov 21.

14.

Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.

Lohm G, Neumann K, Budach V, Wiegel T, Hoecht S, Gollrad J.

Strahlenther Onkol. 2018 Apr;194(4):325-332. doi: 10.1007/s00066-017-1247-1. Epub 2017 Dec 18.

PMID:
29255924
15.

Outcomes of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Lee EK, Mui WH, Chan AW, Tung Y, Wong FC.

Hong Kong Med J. 2018 Jun;24(3):218-225. doi: 10.12809/hkmj176888. Epub 2018 May 21.

16.

Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.

Emmett L, van Leeuwen PJ, Nandurkar R, Scheltema MJ, Cusick T, Hruby G, Kneebone A, Eade T, Fogarty G, Jagavkar R, Nguyen Q, Ho B, Joshua AM, Stricker P.

J Nucl Med. 2017 Dec;58(12):1972-1976. doi: 10.2967/jnumed.117.196683. Epub 2017 Jul 26.

17.

Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.

Cortés-González JR, Castellanos E, Sandberg K, Eriksson MH, Wiklund P, Carlsson S, Cohn-Cedermark G, Harmenberg U, Gustafsson O, Levitt SH, Lennernäs B, Brandberg Y, Márquez M, Kälkner KM, Nilsson S.

Int J Oncol. 2013 Jan;42(1):109-17. doi: 10.3892/ijo.2012.1694. Epub 2012 Nov 13.

PMID:
23151842
18.
19.

Outcomes of extremely low risk prostate cancer following radical prostatectomy.

Lee EW, Laze J, Lepor H.

Prostate Cancer Prostatic Dis. 2011 Sep;14(3):266-9. doi: 10.1038/pcan.2011.21. Epub 2011 May 3.

PMID:
21537347
20.

The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survival.

Bartkowiak D, Bottke D, Thamm R, Siegmann A, Hinkelbein W, Wiegel T.

Radiother Oncol. 2016 Jan;118(1):131-5. doi: 10.1016/j.radonc.2015.10.028. Epub 2015 Nov 30.

PMID:
26653358

Supplemental Content

Support Center